Starsource Multitrade Limited
BBSE:STARSOURCE108.30
INR
-5.70
(-5.00%)
ISIN
INE320M01019
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Ruchit Mehta
- Full Time Employees
- - -
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- 1016, North Plaza Mumbai MA India 380005
- IPO Date
- Jan 2, 1995
- Website
- starsourcemultitrade.com
- Similar Companies
- Business
- Starsource Multitrade Limited engages in pharmaceutical trading and related services as part of the broader Chemo Pharma Laboratories Limited corporate group. It focuses on the sourcing, distribution, and commercialization of pharmaceutical products, chemicals, and related healthcare materials, supported by strategic partnerships and market channel development across its core markets. The company operates through diversified segments within the pharmaceutical ecosystem, emphasizing product sourcing, supply chain coordination, regulatory compliance, and customer relationship management to serve distributors, hospitals, clinics, and pharmaceutical manufacturers. Founding year and headquarters: established within India; headquarters are located in Mumbai, India, with activities and governance aligned to the Chemo Pharma Laboratories Limited corporate framework. The firm’s recent structural and strategic movements include ongoing alliance activity, adjustments to leadership and governance, and efforts to explore or pursue new business opportunities within the power and chemicals space alongside its pharmaceutical focus. As part of its latest developments, the company has reported board-level and management changes, reorganizations, and regulatory disclosures in connection with SEBI and stock exchange requirements, reflecting a broader strategic realignment and pursuit of growth avenues in its portfolio and markets. Industry and structure: operates in the Pharmaceuticals and General Trading sectors with potential ancillary activities in related chemical markets; maintains corporate relationships with Chemo Pharma Laboratories Limited as the parent or controlling entity, with possible subsidiary links and shared branding across its product and service lines. Geographic scope includes operations and market participation primarily within India, with distribution and trading activities that may extend to regional markets as part of its growth strategy. Key products and services: core product categories cover pharmaceutical products, active pharmaceutical ingredients (APIs) and related chemicals, specialty chemicals, medical supplies, and healthcare-focused trading services; services include product sourcing, import/export facilitation, regulatory compliance support, quality assurance coordination, logistics and distribution support, and channel management for resellers and end users. The company emphasizes a systematic listing of its offerings through product families and service types to provide clarity to customers and partners. It maintains a clear focus on expanding its product suite and market reach through strategic partnerships and potential acquisitions aligned with its stated growth plan.